BioLine Rx Stock (NASDAQ:BLRX), Quotes and News Summary

Q: What sector and industry does BioLine Rx (BLRX) operate in?

BioLine Rx is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

BioLine Rx Stock (NASDAQ: BLRX) stock price, news, charts, stock research, profile.

Open	$0.660
Close	-
Volume / Avg.	369.770K / 423.721K
Day Range	0.618 - 0.680
52 Wk Range	0.610 - 2.530
Market Cap	$51.161M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	30
Short Interest	-
Days to Cover	1.27

Recent News

BioLineRx Touts Encouraging Data From Therapy Trial For First Line Pancreatic Cancer

BioLineRx Ltd (NASDAQ: BLRX) announced data from the single-arm pilot phase of the investigator-initiated CheMo4METPANC Phase 2 combination trial of motixafortide and gemcitabine and nab-paclitaxel versus gemcitabine and nab-paclitaxel alone, in first-line

Vandana Singh

Unity Software To Rally Around 60%? Here Are 10 Other Analyst Forecasts For Friday

B of A Securities raised the price target for Unity Software Inc. (NYSE: U) from $46 to $56. B of A Securities analyst Ryan Gee upgraded the stock from Neutral to Buy. Unity Software shares fell 3% to close at $35.71 on Thursday.

Lisa Levin

BioLineRx Highlights Early-Stage Trial Data From Cancer Vaccine Candidate

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trend

Nov 23

Feb

Mar

Apr

Buy

Hold

Sell

Strong Sell

Analyst Rating

4.3

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

About Bioline Rx Ltd

Sector

Health Care

Industry

Biotechnology

BioLine Rx Ltd is a commercial-stage biopharmaceutical company focused on oncology. The company's cu...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy BioLine Rx (BLRX) stock?

You can purchase shares of BioLine Rx (NASDAQ: BLRX) through any online brokerage.

View our list of the best stock brokerages.

Who are BioLine Rx's (BLRX) competitors?

Other companies in BioLine Rx’s space includes: Kezar Life Sciences (NASDAQ:KZR), Gain Therapeutics (NASDAQ:GANX), Intensity Therapeutics (NASDAQ:INTS), Eagle Pharmaceuticals (NASDAQ:EGRX) and Immuneering (NASDAQ:IMRX).

What is the target price for BioLine Rx (BLRX) stock?

The latest price target for BioLine Rx (NASDAQ: BLRX) was reported by HC Wainwright & Co. on Wednesday, April 17, 2024. The analyst firm set a price target for 21.00 expecting BLRX to rise to within 12 months (a possible 3230.69% upside). 7 analyst firms have reported ratings in the last year.

Current Stock Price for BioLine Rx (BLRX)?

The stock price for BioLine Rx (NASDAQ: BLRX) is $0.6305 last updated Today at April 23, 2024 at 3:05 PM EDT.

Does BioLine Rx (BLRX) pay a dividend?

There are no upcoming dividends for BioLine Rx.

When is BioLine Rx (NASDAQ:BLRX) reporting earnings?

BioLine Rx’s Q1 earnings are confirmed for Wednesday, May 22, 2024.

Is BioLine Rx (BLRX) going to split?

There is no upcoming split for BioLine Rx.

What sector and industry does BioLine Rx (BLRX) operate in?

BioLine Rx is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

-

-

-

-

-

-

-

-

-

-

-

-

-

-